SCHEMBL23959783

SCHEMBL23959783

COc1cc2nc(-c3ccccc3)n3ccc(=O)c(c1)c23

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.44
POLB P06746 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ALDH1A1 P00352 5/20 0.43
EGFR P00533 2/20 0.42
NPSR1 Q6W5P4 2/20 0.41
RAB9A P51151 1/20 0.41
KDM4E B2RXH2 4/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HPGD P15428 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NR1H2 P55055 2/20 0.39
NR1H3 Q13133 2/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16613197 0.73 ALDH1A1 (0.46) CYP1A2POLBCYP2C9CYP2C19ALDH1A1
SCHEMBL1462814 0.69 KCNH2 (0.60) CYP1A2POLBCYP2C9CYP2C19ALDH1A1
SCHEMBL9034743 0.69 TUBB4A (0.47) CYP1A2POLBCYP2C9CYP2C19ALDH1A1
SCHEMBL23959772 0.69 TSHR (0.50) CYP2C9CYP2C19ALDH1A1NPSR1RAB9A
SCHEMBL1463663 0.68 KCNH2 (0.59) CYP1A2POLBCYP2C9CYP2C19ALDH1A1
SCHEMBL13325842 0.66 TNK2 (0.47) POLBALDH1A1NPSR1KDM4EMEN1
SCHEMBL6306921 0.65 F11 (0.63) POLBALDH1A1EGFRKDM4EMEN1
SCHEMBL23959794 0.65 SMN1; SMN2 (0.44) POLBALDH1A1RAB9AKDM4EMEN1
SCHEMBL1317721 0.64 KDM4E (0.61) CYP1A2POLBCYP2C9CYP2C19ALDH1A1
SCHEMBL31277481 0.63 ALDH1A1 (0.95) CYP1A2POLBCYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210332038-A1 6H-IMIDAZO[4,5,1-ij]QUINOLONE, SYNTHESIS METHOD AND USE THEREOF HANGZHOU NORMAL UNIVERSITY 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332038-A1 6H-IMIDAZO[4,5,1-ij]QUINOLONE, SYNTHESIS METHOD AND USE THEREOF ABL1, KCNK4, KCNJ4 CYP1A2 239/4885POLB 3695/4885CYP2C9 257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.